PAVAN REDDY to Mice
This is a "connection" page, showing publications PAVAN REDDY has written about Mice.
Connection Strength
1.851
-
Novel regulators of GVHD revealed through microbiome and metabolome patterns across distinct intestinal regions. Blood. 2025 Jun 05; 145(23):2774-2787.
Score: 0.070
-
Inflammation-induced epigenetic imprinting regulates intestinal stem cells. Cell Stem Cell. 2024 Oct 03; 31(10):1447-1464.e6.
Score: 0.067
-
Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models. J Clin Invest. 2024 Mar 01; 134(5).
Score: 0.064
-
Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation. Immunity. 2023 02 14; 56(2):353-368.e6.
Score: 0.060
-
Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology. Nat Immunol. 2021 11; 22(11):1440-1451.
Score: 0.055
-
RNA-seq of human T cells after hematopoietic stem cell transplantation identifies Linc00402 as a regulator of T cell alloimmunity. Sci Transl Med. 2021 03 17; 13(585).
Score: 0.053
-
ER-to-Golgi transport and SEC23-dependent COPII vesicles regulate T cell alloimmunity. J Clin Invest. 2021 01 19; 131(2).
Score: 0.052
-
ATG5-Dependent Autophagy Uncouples T-cell Proliferative and Effector Functions and Separates Graft-versus-Host Disease from Graft-versus-Leukemia. Cancer Res. 2021 02 15; 81(4):1063-1075.
Score: 0.051
-
SNARE protein SEC22B regulates early embryonic development. Sci Rep. 2019 08 07; 9(1):11434.
Score: 0.047
-
miR-142 controls metabolic reprogramming that regulates dendritic cell activation. J Clin Invest. 2019 04 08; 129(5):2029-2042.
Score: 0.046
-
Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition. Nat Microbiol. 2019 05; 4(5):800-812.
Score: 0.046
-
Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation. J Immunol. 2018 12 01; 201(11):3443-3455.
Score: 0.045
-
Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun. 2018 09 10; 9(1):3674.
Score: 0.044
-
Murine Models of Steroid Refractory Graft-versus-Host Disease. Sci Rep. 2018 08 20; 8(1):12475.
Score: 0.044
-
STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity. Biol Blood Marrow Transplant. 2017 Oct; 23(10):1622-1630.
Score: 0.041
-
A Critical Analysis of the Role of SNARE Protein SEC22B in Antigen Cross-Presentation. Cell Rep. 2017 06 27; 19(13):2645-2656.
Score: 0.041
-
Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic Cells. J Innate Immun. 2017; 9(2):126-144.
Score: 0.039
-
Mature T cell responses are controlled by microRNA-142. J Clin Invest. 2015 Jul 01; 125(7):2825-40.
Score: 0.035
-
BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood. 2015 Apr 23; 125(17):2724-8.
Score: 0.035
-
Host CD8a+ dendritic cells may be a key factor for separating graft-versus-host disease from graft-versus-leukemia. Biol Blood Marrow Transplant. 2015 Apr; 21(4):775-6.
Score: 0.034
-
Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice. Blood. 2014 May 29; 123(22):3512-23.
Score: 0.032
-
Allogeneic T cell responses are regulated by a specific miRNA-mRNA network. J Clin Invest. 2013 Nov; 123(11):4739-54.
Score: 0.031
-
Neddylation plays an important role in the regulation of murine and human dendritic cell function. Blood. 2013 Sep 19; 122(12):2062-73.
Score: 0.031
-
Mouse models in bone marrow transplantation and adoptive cellular therapy. Semin Hematol. 2013 Apr; 50(2):131-44.
Score: 0.031
-
Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation. Blood. 2013 May 16; 121(20):4231-41.
Score: 0.030
-
PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6. J Immunol. 2013 Apr 15; 190(8):4005-13.
Score: 0.030
-
Influence of donor microbiota on the severity of experimental graft-versus-host-disease. Biol Blood Marrow Transplant. 2013 Jan; 19(1):164-8.
Score: 0.029
-
Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease. J Leukoc Biol. 2012 Apr; 91(4):667-75.
Score: 0.028
-
Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):564-9.
Score: 0.028
-
Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells. Blood. 2012 Apr 19; 119(16):3844-53.
Score: 0.028
-
Host basophils are dispensable for induction of donor T helper 2 cell differentiation and severity of experimental graft-versus-host disease. Biol Blood Marrow Transplant. 2011 Dec; 17(12):1747-53.
Score: 0.027
-
Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality. Blood. 2011 Jun 09; 117(23):6172-83.
Score: 0.026
-
Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease. Blood. 2011 Jul 07; 118(1):192-204.
Score: 0.026
-
Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation. Clin Cancer Res. 2011 Jan 01; 17(1):77-88.
Score: 0.026
-
A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. J Immunol. 2010 Oct 01; 185(7):3866-72.
Score: 0.025
-
Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner. Blood. 2010 Jan 21; 115(3):724-35.
Score: 0.024
-
Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3. J Immunol. 2009 May 15; 182(10):5899-903.
Score: 0.023
-
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest. 2008 Jul; 118(7):2562-73.
Score: 0.022
-
Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol. 2008 Aug; 36(8):988-96.
Score: 0.021
-
Mouse models of bone marrow transplantation. Biol Blood Marrow Transplant. 2008 Jan; 14(1 Suppl 1):129-35.
Score: 0.021
-
A novel role for the semaphorin Sema4D in the induction of allo-responses. Biol Blood Marrow Transplant. 2007 Nov; 13(11):1294-1303.
Score: 0.021
-
Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease. Exp Hematol. 2007 Feb; 35(2):274-86.
Score: 0.020
-
A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med. 2005 Nov; 11(11):1244-9.
Score: 0.018
-
Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host disease. Blood. 2025 Feb 20; 145(8):881-896.
Score: 0.017
-
Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe. 2024 Sep 11; 32(9):1621-1636.e6.
Score: 0.017
-
Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation. Blood. 2004 Nov 15; 104(10):3393-9.
Score: 0.017
-
Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc Natl Acad Sci U S A. 2004 Mar 16; 101(11):3921-6.
Score: 0.016
-
Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation. Blood Adv. 2023 11 28; 7(22):6936-6948.
Score: 0.016
-
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment. Sci Transl Med. 2022 11 16; 14(671):eabo3445.
Score: 0.015
-
Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood. 2003 Apr 01; 101(7):2877-85.
Score: 0.015
-
Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation. Blood. 2002 Nov 01; 100(9):3429-31.
Score: 0.015
-
A redox cycle with complex II prioritizes sulfide quinone oxidoreductase-dependent H2S oxidation. J Biol Chem. 2022 01; 298(1):101435.
Score: 0.014
-
Colorectal cancer cells utilize autophagy to maintain mitochondrial metabolism for cell proliferation under nutrient stress. JCI Insight. 2021 06 17; 6(14).
Score: 0.013
-
Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis. J Biol Chem. 2021 Jan-Jun; 296:100120.
Score: 0.013
-
Computational analysis of continuous body temperature provides early discrimination of graft-versus-host disease in mice. Blood Adv. 2019 12 10; 3(23):3977-3981.
Score: 0.012
-
MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells. Immunity. 2019 09 17; 51(3):479-490.e6.
Score: 0.012
-
SAG/RBX2 E3 Ubiquitin Ligase Differentially Regulates Inflammatory Responses of Myeloid Cell Subsets. Front Immunol. 2018; 9:2882.
Score: 0.011
-
Survival signal REG3a prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest. 2018 11 01; 128(11):4970-4979.
Score: 0.011
-
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018 03; 24(3):282-291.
Score: 0.011
-
T cell-specific notch inhibition blocks graft-versus-host disease by inducing a hyporesponsive program in alloreactive CD4+ and CD8+ T cells. J Immunol. 2013 Jun 01; 190(11):5818-28.
Score: 0.008
-
Blockade of individual Notch ligands and receptors controls graft-versus-host disease. J Clin Invest. 2013 Apr; 123(4):1590-604.
Score: 0.008
-
Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med. 2011 Jan 26; 3(67):67ra8.
Score: 0.007
-
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood. 2008 Aug 15; 112(4):1515-21.
Score: 0.005
-
Critical role of host gammadelta T cells in experimental acute graft-versus-host disease. Blood. 2005 Jul 15; 106(2):749-55.
Score: 0.004
-
Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. Blood. 2005 Mar 01; 105(5):2023-7.
Score: 0.004
-
Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol. 2004 Jun 15; 172(12):7393-8.
Score: 0.004
-
Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol. 2003 Oct; 31(10):897-902.
Score: 0.004
-
Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood. 2003 Jul 15; 102(2):429-35.
Score: 0.004
-
Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood. 2003 Jul 15; 102(2):763-71.
Score: 0.004
-
Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002 Jun; 8(6):575-81.
Score: 0.004
-
Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest. 2002 May; 109(9):1249-56.
Score: 0.004
-
Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease. Blood. 2002 Mar 01; 99(5):1825-32.
Score: 0.004